These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11260032)

  • 1. Intralesional injection of enoxaparin in benign symmetrical lipomatosis: an alternative to surgery?
    Fischer M; Wohlrab J; Taube KM; Marsch WC
    Br J Dermatol; 2001 Mar; 144(3):629-30. PubMed ID: 11260032
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparins (enoxaparin) in the management of unstable angina: the TIMI studies. Thrombolysis in Myocardial Infarction.
    Gurfinkel E; Scirica BM
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I15-7. PubMed ID: 10469673
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin (enoxaparin) in the management of unstable angina: the ESSENCE study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.
    Fox KA
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I12-4. PubMed ID: 10469672
    [No Abstract]   [Full Text] [Related]  

  • 4. Madelung Disease Treated With Deoxycholic Acid.
    Rodriguez M; Beal BT; Khetarpal S; Vidimos A
    Dermatol Surg; 2021 Jun; 47(6):879-880. PubMed ID: 32897938
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enoxaparin in haemodialysis].
    Olszowska A; Zelichowski G
    Pol Merkur Lekarski; 2002 Nov; 13(77):433-6. PubMed ID: 12621768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesotherapy for benign symmetric lipomatosis.
    Hasegawa T; Matsukura T; Ikeda S
    Aesthetic Plast Surg; 2010 Apr; 34(2):153-6. PubMed ID: 19488808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does enoxaparin have enough FINESSE to replace unfractionated heparin in primary percutaneous coronary intervention?
    Goodman SG
    JACC Cardiovasc Interv; 2010 Feb; 3(2):213-4. PubMed ID: 20170879
    [No Abstract]   [Full Text] [Related]  

  • 8. Choosing a parenteral anticoagulant agent.
    Diuguid DL
    N Engl J Med; 2001 Nov; 345(18):1340-2. PubMed ID: 11794155
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimising outcomes: socioeconomic perspective.
    Mark DB
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I18-20. PubMed ID: 10469674
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic agents and thromboembolic disease.
    Ewenstein BM
    N Engl J Med; 1997 Nov; 337(19):1383-4. PubMed ID: 9358134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 12. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Hornick P;
    Lancet; 2010 Mar; 375(9717):807-15. PubMed ID: 20206776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipolysis of lipomas in patients with familial multiple lipomatosis: an ultrasonography-controlled trial.
    Bechara FG; Sand M; Sand D; Rotterdam S; Stücker M; Altmeyer P; Hoffmann K
    J Cutan Med Surg; 2006; 10(4):155-9. PubMed ID: 17234112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparins in acute coronary syndrome.
    Creekmore F
    S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862
    [No Abstract]   [Full Text] [Related]  

  • 15. Quick, easy, and safe? On the use of low-molecular-weight heparins in cardioversion of atrial fibrillation.
    Stellbrink C
    Eur Heart J; 2006 Dec; 27(23):2742-3. PubMed ID: 17098755
    [No Abstract]   [Full Text] [Related]  

  • 16. ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy.
    Thomas D; Giugliano RP
    J Thromb Thrombolysis; 2009 Jan; 27(1):1-10. PubMed ID: 18931978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis and cancer. An update of our knowledge].
    Tumori; 2006; 92(5):23-41. PubMed ID: 17168451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heparin in the treatment of unstable angina. Can the decrease of the molecular size increase its effectiveness?].
    Panchenko EP
    Ter Arkh; 1998; 70(12):71-4. PubMed ID: 10067259
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent generalized lichen nitidus successfully treated with enoxaparin sodium.
    Cholongitas E; Kokolakis G; Giannikaki E; Ioannidou D
    Am J Clin Dermatol; 2008; 9(5):349-50. PubMed ID: 18717613
    [No Abstract]   [Full Text] [Related]  

  • 20. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.
    Charters MA; Frisch NB; Wessell NM; Dobson C; Les CM; Silverton CD
    J Arthroplasty; 2015 Jul; 30(7):1277-80. PubMed ID: 25724111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.